Intracellular calcium (Ca ++) regulation of cerebral vessels is impaired after subarachnoid hemorrhage (SAH), making secondary pathways, such as that involving apolipoprotein E, potentially more influential. To evaluate cerebrospinal fluid (CSF) apolipoprotein E and Ca++ levels as biomarkers of cerebral vasospasm, we examined changes in levels over time and apolipoprotein E (APOE) ε4 allele presence after SAH in individuals with and without vasospasm. We hypothesized that individuals with low apolipoprotein E levels, increased Ca++ levels and/or at least one copy of the APOE ε4 allele would have vasospasm. Daily samples from 50 participants, aged 18—75, with SAH were used to quantify apolipoprotein E and Ca++ levels. Vasospasm was verified using cerebral angiogram and/or elevated transcranial Dopplers in combination with clinical neurologic deterioration. Overall apolipoprotein E levels were higher in individuals with the APOE ε4 allele (p = .02) or angiographic vasospasm (p = .01), but there were no differences between individuals with and without symptomatic vasospasm. There were no significant changes in apolipoprotein E levels over time. Individuals with the ε4 allele had lower Ca ++ levels (p = .02) with trends suggesting a different pattern of change over time (p = .07). CSF Ca++ levels were lower in individuals with symptomatic vasospasm (p < .01). Change in apolipoprotein E and Ca ++ levels (p = .006) correlated over time regardless of genotype or vasospasm status. These findings suggest that apolipoprotein E and Ca ++ may be interacting after SAH, but this interaction does not appear to influence vasospasm.
Arai, T., Takeyama, N., & Tanaka, T. (2000). Glutathione monoethyl ester and inhibition of the oxyhemoglobin-induced increase in cytosolic calcium in cultured smooth-muscle cells. Journal of Neurosurgery, 93, 527-532.
2.
Dunn, L.T., Stewart, E., Murray, G.D., Nicoll, J.A., & Teasdale, G.M. (2001). The influence of apolipoprotein E genotype on outcome after spontaneous subarachnoid hemorrhage: A preliminary study. Neurosurgery, 48, 1006-1010, discussion 1010-1001.
3.
d'Uscio, L.V., Baker, T.A., Mantilla, C.B., Smith, L., Weiler, D., Sieck, G.C., et al. (2001). Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice. Arteriosclerosis, Thrombosis & Vascular Biology, 21, 1017-1022.
4.
Fisher, C.M., Kistler, J.P., & Davis, J.M. (1980). Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery, 6, 1-9.
5.
Fujii, S., & Fujitsu, K. (1988). Experimental vasospasm in cultured arterial smooth-muscle cells. Journal of Neurosurgery, 69, 92-97.
6.
Gao, J., Wang, H., Sheng, H., Lynch, J.R., Warner, D.S., Durham, L., et al. (2006). A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage . Neurocritical Care, 4, 25-31.
7.
Guillaume, D., Bertrand, P., Dea, D., Davignon, J., & Poirier, J. (1996). Apolipoprotein E and low-density lipoprotein binding and internalization in primary cultures of rat astrocytes: Isoform-specific alterations. Journal of Neuro-chemistry, 66, 2410-2418.
8.
Haley, E.C. Jr, Kassell, N.F., Alves, W.M., Weir, B.K., & Hansen, C.A. (1995). Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. Journal of Neurosurgery, 82, 786-790.
9.
Haley, E.C. Jr, Kassell, N.F., & Torner, J.C. (1992). The International Cooperative Study on the Timing of Aneurysm Surgery. The North American experience. Stroke , 23, 205-214.
10.
Hixson, J.E., & Vernier, D.T. (1990). Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. Journal of Lipid Research, 31, 545-548.
11.
Ignatius, M.J., Gebicke-Harter, P.J., Skene, J.H., Schilling, J.W., Weisgraber, K.H., Mahley, R.W., et al. (1986). Expression of apolipoprotein E during nerve degeneration and regeneration. Proceedings of the National Academy of Sciences of the United States of America, 83, 1125-1129.
12.
Kandel, E.R., Schwartz, J.H., & Jessel, T.M. (2000). Principles of Neural Science (4th ed.). New York: McGraw-Hill.
13.
Kay, A., Petzold, A., Kerr, M., Keir, G., Thompson, E., & Nicoll, J. (2003a). Temporal alterations in cerebrospinal fluid amyloid beta-protein and apolipoprotein E after subarachnoid hemorrhage. Stroke, 34, 240-243.
14.
Kay, A.D., Petzold, A., Kerr, M., Keir, G., Thompson, E., & Nicoll, J. (2003b). Decreased cerebrospinal fluid apolipoprotein E after subarachnoid hemorrhage: Correlation with injury severity and clinical outcome. Stroke, 34, 637-642.
15.
Kim, C.J., Kim, K.W., Park, J.W., Lee, J.C., & Zhang, J.H. (1999). Role of Ca(2+)-dependent K+ channels in erythrocyte lysate-induced contraction of rabbit cerebral artery. Neurological Research, 21, 705-711.
16.
Lanterna, L.A., Rigoldi, M., Tredici, G., Biroli, F., Cesana, C., Gaini, S.M., et al. (2005). APOE influences vasospasm and cognition of noncomatose patients with subarachnoid hemorrhage. Neurology , 564, 1237-1244.
17.
Lanzino, G., & Kassell, N.F. (1999). Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America. Journal of Neurosurgery, 90, 1018-1024.
18.
Leung, C.H., Poon, W.S., Yu, L.M., Wong, G.K., & Ng, H.K. (2002). Apolipoprotein E genotype and outcome in aneurysmal subarachnoid hemorrhage. Stroke, 33, 548-552.
19.
Lin, C., Duan, H., & Mazzone, T. (1999). Apolipoprotein E-dependent cholesterol efflux from macrophages: Kinetic study and divergent mechanisms for endogenous versus exogenous apolipoprotein E. Journal of Lipid Research, 40, 1618-1627.
20.
Macdonald, R.L., Weir, B.K., Grace, M.G., & Takenaka, K. (1991). Induction of cytosolic free calcium elevation in rat vascular smooth-muscle cells by cerebrospinal fluid from patients after subarachnoid hemorrhage. Journal of Neurosurgery, 75, 425-432.
21.
Macdonald, R.L., Weir, B.K., Marton, L.S., Zhang, Z.D., Sajdak, M., Johns, L.M., et al. (2001). Role of adenosine 5'-triphosphate in vasospasm after subarachnoid hemorrhage: Human investigations. Neurosurgery , 48, 854-862 discussion 862-853.
22.
Mesis, R.G., Wang, J., Lombard, F.W., Yates, R.R., Vitek, M.P., OBorel, C.B., et al. (2006). Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage. Neurosurgical Focus, 21, E4.
23.
Morris, P.G., Wilson, J., Dunn, L., & Nicoll, J. (2004). Apolipoprotein E polymorphism and neuropsychological outcome following subarachnoid haemorrhage. Acta Neurologica Scandinavica. Supplementum, 109, 205-209.
24.
Muller, W., Meske, V., Berlin, K., Scharnagl, H., Marz, W., & Ohm, T.G. (1998). Apolipoprotein E isoforms increase intracellular Ca2+ differentially through an omegaagatoxin IVa-sensitive Ca2+-channel. Brain Pathology, 8, 641-653.
25.
Nathan, B.P., Bellosta, S., Sanan, D.A., Weisgraber, K.H., Mahley, R.W., & Pitas, R.E. (1994). Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science, 264, 850-852.
26.
Nathan, B.P., Jiang, Y., Wong, G.K., Shen, F., Brewer, G.J., & Struble, R.G. (2002). Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein. Brain Research, 928, 96-105.
27.
Niskakangas, T. (2001). Association of apolipoprotein E polymorphism with outcome after aneurysmal subarachnoid hemorrhage: A preliminary study. Stroke, 32, 1181-1184.
28.
Ohman, J. (1991). Risks factors for cerebral infarction in good-grade patients after aneurysmal subarachnoid hemorrhage and surgery: A prospective study. Journal of Neurosurgery, 74, 14-20.
29.
Skene, J.H., & Shooter, E.M. (1983). Denervated sheath cells secrete a new protein after nerve injury. Proceedings of the National Academy of Sciences of the United States of America, 80, 4169-4173.
30.
Steele, J.A., Stockbridge, N., Maljkovic, G., & Weir, B. (1991). Free radicals mediate actions of oxyhemoglobin on cerebrovascular smooth muscle cells. Circulation Research , 68, 416-423.
31.
Stoll, G., Meuller, H.W., Trapp, B.D., & Griffin, J.W. (1989). Oligodendrocytes but not astrocytes express apolipoprotein E after injury of rat optic nerve. GLIA, 2, 170-176.
32.
Stoll, G., & Muller, H.W. (1986). Macrophages in the peripheral nervous system and astroglia in the central nervous system of rat commonly express apolipoprotein E during development but differ in their response to injury. Neuroscience Letters, 72, 233-238.
33.
Tang, J., Zhao, J., Zhao, Y., Wang, S., Chen, B., & Zeng, W. (2003). Apolipoprotein E epsilon4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage. Surgical Neurology, 60, 391-396.
34.
Tolar, M., Keller, J., Chan, S., Mattson, M., Marques, M., & Crutcher, K. (1999). Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity. Journal of Neuroscience, 19, 7100-7110.
35.
Veinbergs, I., Everson, A., Sagara, Y., & Masliah, E. (2002). Neurotoxic effects of apolipoprotein E4 are mediated via dysregulation of calcium homeostasis. Journal of Neuroscience Research, 67, 379-387.
36.
Vollrath, B., Weir, B., & Cook, D.A. (1990). Hemoglobin causes release of inositol trisphosphate from vascular smooth muscle. Biochemical & Biophysical Research Communications, 171, 506-511.
37.
Wang, J., Ohta, S., Sakaki, S., Araki, N., Matsuda, S., & Sakanaka, M. (1994). Changes in Ca(++)-ATPase activity in smooth-muscle cell membranes of the canine basilar artery with experimental subarachnoid hemorrhage. Journal of Neurosurgery, 80, 269-275.
38.
Weir, B. (1995). The pathophysiology of cerebral vasospasm. British Journal of Neurosurgery, 9, 375-390.
39.
Weisgraber, K.H. (1994). Apolipoprotein E: Structure-function relationships . Advances in Protein Chemistry, 45, 249-302.
